Serum magnesium measures the concentration of magnesium in your blood, a cofactor essential for over 300 enzyme systems, ATP synthesis, DNA stability, vascular tone, and insulin signaling. Although serum magnesium represents only about 1% of total body magnesium (most resides intracellularly), a low serum level is a pragmatic first-line indicator of whole-body depletion and predicts cardiovascular dysfunction, arrhythmias, impaired glucose handling, and migraine.
Analyzed in accredited Swedish clinical laboratories (ISO 15189). Used to support clinician-directed evaluation and monitoring. Not a stand-alone diagnosis.
This is a directly measured biomarker — serum magnesium is measured via atomic absorption or ion-selective electrode. Note: serum magnesium is an imperfect mirror of total body magnesium stores; intracellular magnesium and red blood cell magnesium are more sensitive indices of whole-body status, but serum testing remains the practical first-line approach in standard clinical settings.
If you experience muscle cramps, fatigue, irregular heartbeat, or migraines, or if you take medications that deplete magnesium (acid-reflux drugs, diuretics), serum magnesium testing reveals whether depletion is contributing to your symptoms. Magnesium is a founding mineral for energy metabolism, vascular relaxation, and electrical stability in the heart, so a low level can manifest across multiple body systems.
Magnesium matters especially if you have metabolic dysfunction—elevated blood sugar, insulin resistance, or metabolic syndrome—because magnesium is required for insulin secretion and glucose disposal. Poor glycemic control drains magnesium through increased urinary wasting. Conversely, magnesium depletion impairs insulin signaling, creating a vicious cycle. Magnesium testing contextualizes whether your glycemic control or metabolic dysfunction is aggravated by mineral shortage.
The Swedish population often sits near the lower bound of normal magnesium intake and serum levels due to low-magnesium soil, processed foods, and water softening. Testing establishes a baseline and is especially valuable if you have cardiovascular risk factors, are on chronic medications, or want a longevity baseline.
Reveals ATP production and energy metabolism status. Magnesium is the central cofactor for ATP synthesis; low serum magnesium signals impaired cellular energy availability and can explain fatigue, exercise intolerance, or slow recovery.
Flags cardiovascular and arrhythmia risk. Magnesium maintains vascular smooth-muscle relaxation and cardiac electrical stability; depletion raises the risk of hypertension, arrhythmias, and sudden cardiac death, independent of blood pressure or lipid levels.
Clarifies migraine and muscle-cramp aetiology. Low magnesium is a known trigger for migraine and muscle cramps; testing distinguishes whether these symptoms are nutritional, genetic, or medication-induced, guiding intervention strategy.
Contextualizes glycemic control and insulin resistance. Magnesium is essential for insulin secretion and glucose disposal; low serum magnesium clusters with HbA1c elevation and predicts future diabetes risk independent of fasting glucose or conventional metabolic markers.
Identifies medication-driven depletion. Proton-pump inhibitors, loop and thiazide diuretics, and many other common drugs deplete magnesium chronically; testing reveals whether drug-induced loss is the primary driver, informing medication review or supplementation strategy.
Assesses bone health context. Magnesium is required for bone mineralization and calcium regulation; low magnesium elevates fracture risk independent of calcium or vitamin D levels, particularly when combined with poor glycemic control or oestrogen deficiency.
The central role of magnesium in cellular and whole-body function. Magnesium is a divalent cation and an obligatory cofactor for over 300 enzyme systems, including all ATP-binding reactions. It activates the Na+/K+ ATPase pump that maintains cellular electrical gradients, participates in DNA and RNA synthesis, stabilizes ribosomal structure, and regulates neurotransmitter release. Without adequate magnesium, cells cannot produce energy, repair DNA, transmit electrical signals, or relax smooth muscle. This is not a optional micronutrient; it is foundational to cellular life.
How magnesium controls vascular and cardiac function. Magnesium is the natural calcium antagonist in vascular smooth muscle: it keeps arteries relaxed and blood pressure low. Low magnesium removes this brake, allowing uncontrolled calcium influx that drives vasoconstriction, hypertension, and arterial stiffness. In the heart, magnesium stabilizes electrical conduction and prevents ectopic firing; depletion raises the risk of atrial fibrillation, ventricular arrhythmias, and sudden cardiac death. Epidemiological data links low magnesium intake to hypertension, coronary heart disease, and stroke; mechanistic studies show that magnesium supplementation lowers blood pressure by 3–5 mmHg on average, and case series show that magnesium infusion can terminate acute arrhythmias.
Magnesium and glucose metabolism. Magnesium is required for tyrosine-kinase activation at the insulin receptor, glucose transporter trafficking, and pyruvate dehydrogenase activation. In insulin resistance and poorly controlled diabetes, elevated urinary magnesium wasting depletes serum magnesium, further impairing glucose disposal—a self-amplifying cycle. Observational studies consistently show that lower serum magnesium is associated with higher diabetes incidence and worse glycemic control. RCT data is mixed regarding supplementation, but the mechanistic basis is clear: magnesium depletion aggravates metabolic dysfunction.
Why serum magnesium is an imperfect but pragmatic marker. Total body magnesium stores are ~24 g, with 99% intracellular (50% in bone, 45% in muscle, 5% in soft tissue) and only ~1% in serum. Serum magnesium is therefore a crude proxy for whole-body status. Red blood cell (RBC) magnesium or urinary magnesium loading tests are more sensitive indicators, but they are rarely measured outside specialized settings. Serum magnesium remains the first-line test because it is widely available, rapid, and low-cost; paired with Phosphate, Calcium, and Potassium levels, it gives a complete electrolyte and mineral picture; a low serum value reliably indicates systemic depletion, though a normal serum value does not rule out intracellular deficiency.
Identifies hidden cardiovascular risk. Low magnesium is an independent predictor of cardiovascular events, arrhythmias, and sudden cardiac death, independent of blood pressure, LDL cholesterol, or other traditional risk factors. Even within the “normal” range, the lowest quartile of serum magnesium is associated with measurably higher CV mortality.
Clusters with metabolic syndrome and insulin resistance. Magnesium depletion and insulin resistance form a bidirectional cycle: poor glucose control drives urinary magnesium wasting, and low magnesium impairs insulin signaling. Testing reveals whether metabolic dysfunction is amplified by mineral shortage, informing whether supplementation or dietary intervention should be prioritized.
Explains medication-induced side effects. Proton-pump inhibitors (used chronically by millions for reflux) reduce magnesium absorption by 25–30%; loop and thiazide diuretics increase urinary wasting. Chronic statin therapy may also deplete magnesium. Testing reveals whether symptoms (muscle pain, fatigue, arrhythmias, migraines) are drug-induced, guiding medication review or targeted supplementation.
Predicts fracture risk independent of bone density. Low magnesium is associated with low bone mineral density and elevated fracture risk, particularly in postmenopausal women and people with poor glycemic control. The association persists after adjusting for Calcium and Vitamin D, suggesting magnesium is a distinct lever for skeletal health.
Standard Swedish clinical reference (0.70–1.05 mmol/L): This is the typical range reported by Swedish clinical laboratories as “normal”. Values within this band are not flagged as abnormal, but the granularity reveals meaningful differences in metabolic function within this broad range.
European guidelines and cardiovascular risk stratification (<0.75 mmol/L = low risk): ESC and related guidelines suggest that serum magnesium <0.75 mmol/L (particularly <0.70 mmol/L) marks the threshold for increased cardiovascular and arrhythmia risk. Values in the 0.85–1.05 mmol/L band are associated with lower CV event rates in prospective cohorts.
Loovi optimal (longevity baseline): ≥0.85 mmol/L, preferably in the upper half of the normal range (0.90–1.05 mmol/L). This aligns with the CV risk reduction seen in longitudinal studies and represents the magnesium status associated with optimal ATP production, vascular relaxation, and glucose handling.
The shift from 0.75 to 0.85 mmol/L is clinically significant: people in the lower quartile (<0.75) face measurably elevated cardiovascular risk and are more susceptible to arrhythmias. For longevity optimization, aiming for the upper half of normal (≥0.85 mmol/L) captures the lowest disease risk and best energy metabolism.
Low (<0.75 mmol/L). This indicates probable whole-body magnesium depletion and warrants investigation for causative factors: chronic PPI or diuretic use, poor dietary intake, alcohol abuse, diarrhoea, or malabsorption. Low magnesium at this level increases risk of cardiac arrhythmias, hypertension, impaired glucose tolerance, and muscle cramps. People in this range often report fatigue, muscle pain, or irregular heartbeats. The low level also amplifies cardiovascular risk from other sources (high ApoB, elevated hs-CRP) and should prompt both dietary and medication review.
Borderline-low (0.75–0.85 mmol/L). This range is technically “normal” by standard laboratory reporting, but sits in the lower quartile of serum magnesium and is associated with elevated cardiovascular risk relative to the upper-normal range. If you have other metabolic risk factors (elevated HbA1c, insulin resistance, hypertension), this level warrants dietary investigation and possible supplementation. Symptoms like fatigue, migraines, or muscle cramps at this level often improve with dietary magnesium increase or supplementation.
Optimal (0.85–1.05 mmol/L). This range reflects healthy whole-body magnesium stores and is associated with the lowest cardiovascular risk, best glucose handling, and optimal ATP production. People in this range typically report good energy, stable blood pressure, and no muscle cramps. Maintaining this level through diet or supplementation is a key longevity lever.
High (>1.05 mmol/L). Very high serum magnesium is rare in free-living populations and usually indicates renal insufficiency (impaired urinary excretion), though it can also be seen with severe diarrhoea-induced dehydration or acute rhabdomyolysis. If renal function is normal, no action is needed. If renal function is impaired, high magnesium may need monitoring to prevent symptomatic hypermagnesiemia (neurological symptoms, cardiac conduction abnormalities).
Factors that influence magnesium. Medications: proton-pump inhibitors, H2 blockers, loop and thiazide diuretics, bisphosphonates (osteoporosis drugs), and aminoglycosides all reduce magnesium. Gut health matters: diarrhoea (from inflammatory bowel disease, celiac disease, irritable bowel syndrome, or infection) impairs absorption; gastroparesis slows uptake. Alcohol and poorly controlled diabetes increase urinary wasting. Intense exercise and sauna use increase transient urinary magnesium loss. Recent vaccination, acute illness, or stress can shift magnesium transiently. Menstrual cycle and female hormonal status influence magnesium metabolism subtly, though the effect is much smaller than for Calcium, Potassium, or Phosphate. Coordination of these four minerals—Magnesium, Calcium, Potassium, and Phosphate—is essential for optimal cardiac electrical function.
Medication-induced depletion. Proton-pump inhibitors (omeprazole, pantoprazole) reduce magnesium absorption by ~25% and are among the most common culprits in chronic low magnesium. Loop and thiazide diuretics increase urinary magnesium wasting. Bisphosphonates (for osteoporosis), aminoglycosides (antibiotics), and some chemotherapy agents also deplete magnesium. If you are on chronic PPI or diuretic therapy, serum magnesium monitoring is prudent.
Dietary insufficiency. Magnesium-rich foods include leafy greens (spinach, kale), nuts and seeds, whole grains, legumes, and hard water. The modern food supply is often magnesium-poor due to soil depletion, food processing, and water softening (which removes magnesium). Populations eating primarily refined carbohydrates and ultra-processed foods face endemic low intake. The Swedish population, with soft water and processed-food reliance, often sits near the lower end of normal serum magnesium.
Gastrointestinal malabsorption. Inflammatory bowel disease (Crohn's disease, ulcerative colitis), celiac disease, irritable bowel syndrome, and chronic diarrhoea all impair magnesium absorption. Even mild diarrhoea can worsen magnesium status over weeks to months.
Diabetes and poor glycemic control. Elevated blood glucose drives urinary magnesium wasting (glycosuria forces osmotic diuresis). People with HbA1c >7.0% are at high risk for magnesium depletion, which in turn worsens insulin resistance—a negative feedback loop. Improving glycemic control through diet and activity naturally restores magnesium.
Alcohol abuse. Ethanol increases urinary magnesium wasting and impairs absorption. Chronic heavy alcohol consumption is a classic risk factor for hypomagnesaemia and is associated with arrhythmias, cardiomyopathy, and neurological dysfunction partly mediated by magnesium depletion.
Nutrition: magnesium-dense whole foods. Leafy greens (spinach, Swiss chard, kale), pumpkin seeds, almonds, black beans, chickpeas, lentils, and whole grains are rich sources. Unrefined, whole-plant foods retain magnesium; refined grains lose 80% of magnesium during milling. Tap water hardness (measured in minerals including magnesium) contributes meaningfully to daily intake in areas with hard water; soft water contributes little. Increasing dietary magnesium through whole foods is the first lever and often sufficient to raise serum magnesium by 0.05–0.15 mmol/L within 4–8 weeks if baseline dietary intake was low.
Medication review and alternatives. If you are on chronic PPI therapy for reflux, ask your doctor whether H2-blocker or lower-dose alternatives are feasible; these deplete magnesium less severely. If on a diuretic, a potassium-sparing formulation (e.g., spironolactone, amiloride) or concurrent ACE inhibitor may be better for overall mineral balance. Medication change requires clinical discussion—never stop medications unilaterally—but optimizing drug regimen is often the highest-impact intervention for people on chronic pharmacotherapy.
Supplementation when appropriate. Magnesium supplements (glycinate, malate, threonate, citrate formulations) are well-tolerated and absorbed. Doses of 200–400 mg daily can raise serum magnesium by 0.1–0.2 mmol/L in deficient individuals over 4–8 weeks. The form matters: glycinate and threonate have better bioavailability and GI tolerance than oxide or carbonate. Supplementation is most effective when combined with dietary increase and removal of depleting medications.
Reducing alcohol and improving glycemic control. Limiting alcohol and normalizing blood glucose through improved carbohydrate quality and physical activity naturally reduce magnesium wasting and allow repletion. For people with metabolic syndrome or diabetes, improving HbA1c from 6.5% to <5.5% often restores serum magnesium by 0.1–0.2 mmol/L without targeted supplementation.
Physical activity and stress management. Regular aerobic and resistance training improve insulin sensitivity and reduce urinary magnesium wasting. Stress-reduction practices (meditation, quality sleep, adequate recovery) lower cortisol and may stabilize serum magnesium. Although exercise itself causes transient urinary magnesium loss, the net effect of regular training is improved magnesium retention through better metabolic control.
The right approach depends on the individual’s baseline serum magnesium, concurrent medications, glycemic control, dietary pattern, and other biomarkers (calcium, phosphate, potassium, vitamin D, HbA1c)—a synthesis that a Loovi longevity doctor maps out in consultation to optimize your full mineral and metabolic picture.
Magnesium is one lever among many in cardiovascular and metabolic health. A person with serum magnesium 0.88 mmol/L but HbA1c 6.8% and ApoB 1.1 g/L faces compounding metabolic risk: poor glucose control is driving magnesium wasting, and elevated lipoprotein particles are driving atherosclerotic burden, regardless of magnesium status. Conversely, someone with magnesium 0.78 mmol/L but otherwise excellent metabolic markers (HbA1c <5.2%, ApoB <0.75 g/L, hs-CRP <1.0 mg/L, potassium and calcium normal) may have relatively low immediate cardiovascular risk but would still benefit from dietary or supplementary magnesium to optimize ATP production and vascular relaxation.
Without the context of calcium, potassium, phosphate, and vitamin D, you cannot assess bone health or broader mineral status. Without HbA1c and fasting insulin, you cannot distinguish whether low magnesium is from poor glycemic control (reversible) or primary depletion from medications (requiring drug review). Without blood pressure, ApoB, and hs-CRP, you cannot quantify cardiovascular risk attributable to magnesium depletion versus other drivers.
The Loovi Membership measures 120+ biomarkers annually, including the full mineral panel (magnesium, calcium, phosphate, potassium), glucose control (HbA1c, fasting glucose, fasting insulin), lipid and inflammation markers (ApoB, LDL, HDL, Lp(a), hs-CRP), and micronutrients (vitamin D, iron, zinc). Paired with unrushed 1-on-1 longevity doctor consultations, physical performance tests (strength, mobility, VO2 max), and an evolving personalized health plan, Loovi hands off the difficult work of interpretation and integration to clinical experts. From 295 SEK/month, Friskvårdsbidrag-approved, with drop-in testing at 80+ Swedish clinics and results in 3 days.
Magnesium depletion is a well-documented cause of muscle cramps, myalgia, and fatigue; if your serum magnesium is <0.80 mmol/L and you have these symptoms, supplementation or dietary increase is highly likely to help. However, muscle cramps and fatigue are non-specific and can reflect thyroid dysfunction (TSH, fT4), iron deficiency (ferritin, serum iron), inadequate sleep, or overtraining. Testing thyroid function, iron status, and your full metabolic panel contextualize whether magnesium is the primary driver or a contributor among multiple factors. Serial measurement after dietary or supplementary intervention (4–8 weeks) confirms whether magnesium repletion improved your symptoms.
Palpitations are most commonly benign (premature atrial or ventricular contractions), but they can reflect arrhythmia risk. Even “normal” serum magnesium in the lower-normal range (0.75–0.85 mmol/L) is associated with elevated arrhythmia risk relative to the upper-normal range (0.95–1.05 mmol/L). Paired with potassium, calcium, magnesium, fasting glucose, and electrocardiography, a complete picture emerges: if you have low-normal magnesium plus elevated fasting insulin or HbA1c, your arrhythmia risk is amplified. If magnesium is low-normal but potassium is also low-normal, mineral deficiency is likely the driver. ECG and Holter monitoring (if palpitations are frequent) help distinguish benign ectopy from genuine arrhythmia; if true arrhythmia is detected, magnesium repletion is a foundational intervention.
Dietary increase alone is sufficient for mild magnesium depletion (0.80–0.85 mmol/L). If you systematically increase magnesium-rich foods (leafy greens, nuts, seeds, whole grains, legumes) and your baseline intake was very low, serum magnesium typically rises 0.05–0.15 mmol/L within 4–8 weeks. However, if your serum magnesium is <0.75 mmol/L, or if you are on chronic PPI or diuretic therapy (which actively deplete magnesium), dietary increase alone may not be sufficient: supplementation is faster and more reliable. The combination of diet increase plus supplementation (200–300 mg/day in divided doses) typically raises serum magnesium 0.15–0.25 mmol/L over 8 weeks.
Magnesium, calcium, and vitamin D are synergistic for bone health. Low magnesium impairs vitamin D activation and calcium absorption; low vitamin D reduces magnesium absorption and increases urinary wasting. The three minerals work as a system: adequate magnesium (≥0.85 mmol/L) permits efficient calcium absorption and vitamin D activation, while low magnesium undermines the benefits of vitamin D or calcium supplementation alone. If you are concerned about bone health and supplementing with vitamin D and calcium, testing serum magnesium ensures you are not inadvertently creating a relative deficiency in the third pillar of bone metabolism.
Magnesium supplements can bind certain medications and reduce absorption. Bisphosphonates (osteoporosis drugs), tetracycline and quinolone antibiotics, and some others should be spaced 2–4 hours apart from magnesium supplements. If you are on any chronic medication, discuss supplementation with your doctor or pharmacist to check for interactions. Most common medications (statins, ACE inhibitors, beta-blockers, SSRIs, thyroid hormone) have minimal interaction with magnesium, but confirmation prevents surprises.
In people with hypertension and concurrent magnesium depletion, supplementation or dietary increase can lower systolic blood pressure by 3–5 mmHg on average. The effect is modest but meaningful at the population level. If your magnesium is <0.80 mmol/L and you have hypertension, repletion is a foundational intervention. However, blood pressure is determined by many factors: salt intake, physical activity, stress, sleep, obesity, glucose control, and sympathetic tone all matter more than magnesium alone. A Loovi doctor contextualizes your blood pressure in relation to your full biomarker profile (ApoB, glucose, hs-CRP, potassium, magnesium) and lifestyle to identify the highest-leverage interventions.
Serum magnesium is the practical first-line test and is adequate for most clinical decisions. If serum magnesium is low (<0.75 mmol/L), it reliably indicates whole-body depletion. If serum magnesium is normal but you have persistent symptoms (cramps, fatigue, arrhythmias) despite dietary attempts, RBC magnesium or urinary magnesium-to-creatinine ratio can reveal intracellular deficiency, but these tests are specialized and not widely available in standard Swedish vårdcentral labs. Loovi measures serum magnesium as part of the standard annual mineral panel; if results warrant deeper investigation, that is a conversation for the longevity doctor consultation.
In people with baseline magnesium deficiency (<0.80 mmol/L), supplementation with 200–300 mg/day (in a well-absorbed form like glycinate) typically raises serum magnesium by 0.10–0.20 mmol/L within 4–8 weeks, depending on the severity of baseline depletion and whether dietary intake is simultaneously increased. The repletion is slower if you are still taking magnesium-depleting medications (PPI, diuretics) without change, because the medication continues to drive urinary or intestinal losses. For fastest and most reliable repletion, combine supplementation with dietary increase and, if medically feasible, medication review to minimize ongoing depletion.
Serum magnesium is a standard test and is typically available through Swedish vårdcentral if ordered by a physician. However, routine screening is not standard care unless there is a specific clinical indication (symptoms, medication use, metabolic risk). Loovi measures serum magnesium as part of the standard annual biomarker panel for all members, regardless of symptoms. If you suspect magnesium depletion and want testing through vårdcentral, ask your physician directly; if testing is refused or delayed, a private longevity service like Loovi provides rapid access and fuller contextual interpretation.
